The study aimed to estimate the prevalence of lipid abnormalities in Iranian adults by
demographic characterization, geographical distribution, and associated risk factors using …

Background Hypercholesterolemia is one of the modifiable risk factors for atherosclerosis
and cardiovascular diseases. Prevention and treatment of hypercholesterolemia and other …

Background: Chronic and abnormal increase of different types of dyslipidemia leads to some
important diseases, such as constriction and abstraction of vessels in various parts of the …

Background Atherogenic dyslipidemia (AD) is a blood serum lipid profile abnormality
characterized by elevation of triglycerides and reduced levels of high density lipoprotein …

More than 80% cardiovascular disease (CVD) is preventable despite the fact that it is
currently the ultimate cause of disability in the world. Assessment of the nationwide …

Objectives To determine the prevalence and patterns of dyslipidemia and its associated risk
factors among patients with type 2 diabetes attending the National Center for Diabetes …

Background Diabetic dyslipidemia is a complex multidimensional abnormality. However,
earlier studies did not focus on the prevalence of various patterns of dyslipidemia. We …

Background Combination of dyslipidemic phenotypes, including elevated plasma levels of
low‐density lipoprotein cholesterol (LDL‐C), elevated plasma triglycerides (TG), and …

Background To examine trends in the population levels of serum lipids among a Middle-
Eastern adult population with high prevalence of dyslipidemia. Methods A population-based …

Background. Dyslipidemia is one of the major modifiable risk factors for the development of
cardiovascular disease and type two diabetes mellitus. Knowing the current prevalence of …